Apr 23, 2017 - Subjects at high risk of developing Alzheimer’s—but who don’t actually have the disease—are being recruited to help test two experimental treatments from Novartis AG, in a new focus on preventive treatment.
Apr 23, 2017 - Looking to buy biotech stocks? Here are 7 important things to know.
Apr 21, 2017 - We expect biotech major Amgen Inc. (AMGN) to beat expectations when it reports first-quarter 2017 results on Apr 26 after the market closes.
Apr 20, 2017 - Eli Lilly and Company (LLY) will report first-quarter 2017 results on Apr 25, before the market opens.
Apr 20, 2017 - Swiss pharmaceutical company Novartis AG (NVS) is scheduled to report first-quarter 2017 results on Apr 25.
Apr 20, 2017 - Biogen Inc. (BIIB), a well-known name in the multiple sclerosis (MS) market, will report first-quarter 2017 results on Apr 25, before the market opens.
Apr 20, 2017 - Centene Corporation (CNC)will release first-quarter 2017 results on Apr 25, before the market opens.
Apr 19, 2017 - Johnson & Johnson (JNJ) reported mixed first-quarter 2017 earnings results on Tuesday.
Apr 18, 2017 - The Zacks Analyst Blog Highlights: Alphabet, Amgen, Lowe’s, Bristol-Myers and Priceline
Apr 17, 2017 - Top Research Reports for Alphabet, Amgen & Lowe's